As expected, after TLR9 agonist CpGB stimulation the percentage of IL-6+ B cells increased in acute COVID-19 patients vs. healthy controls and convalescent patients irrespective of possible chest X-ray abnormality (Shuwa et al., 2021). The gene discussed is IL6; the disease is COVID-19.